[go: up one dir, main page]

HUT68042A - Piperazides of substituted phenylalanine derivates as thrombin inhibitors - Google Patents

Piperazides of substituted phenylalanine derivates as thrombin inhibitors

Info

Publication number
HUT68042A
HUT68042A HU9402923A HU9402923A HUT68042A HU T68042 A HUT68042 A HU T68042A HU 9402923 A HU9402923 A HU 9402923A HU 9402923 A HU9402923 A HU 9402923A HU T68042 A HUT68042 A HU T68042A
Authority
HU
Hungary
Prior art keywords
pct
piperazides
derivates
thrombin inhibitors
substituted phenylalanine
Prior art date
Application number
HU9402923A
Other languages
Hungarian (hu)
Other versions
HU9402923D0 (en
Inventor
Joerg Stuerzebecher
Helmut Vieweg
Peter Wikstroem
Christoph Adler
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of HU9402923D0 publication Critical patent/HU9402923D0/en
Publication of HUT68042A publication Critical patent/HUT68042A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PCT No. PCT/CH94/00026 Sec. 371 Date Jan. 5, 1995 Sec. 102(e) Date Jan. 5, 1995 PCT Filed Feb. 9, 1994 PCT Pub. No. WO94/18185 PCT Pub. Date Aug. 18, 1994The present invention relates to D,L-, L- and D-phenylalanine piperazides of formula (I) defined in claim 1 that inhibit blood coagulation, and thrombin and/or trypsin, respectively. The compounds are extraordinarily absorbable after oral, intraduodenal and in particular rectal administration and show only a low toxicity.
HU9402923A 1993-02-10 1994-02-09 Piperazides of substituted phenylalanine derivates as thrombin inhibitors HUT68042A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH40593 1993-02-10
CH282793 1993-09-20

Publications (2)

Publication Number Publication Date
HU9402923D0 HU9402923D0 (en) 1995-01-30
HUT68042A true HUT68042A (en) 1995-03-22

Family

ID=25684484

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402923A HUT68042A (en) 1993-02-10 1994-02-09 Piperazides of substituted phenylalanine derivates as thrombin inhibitors

Country Status (11)

Country Link
US (1) US5607937A (en)
EP (1) EP0635008B1 (en)
JP (1) JPH07509731A (en)
KR (1) KR950703543A (en)
AT (1) ATE223392T1 (en)
AU (1) AU5878194A (en)
CA (1) CA2133761A1 (en)
CZ (1) CZ245994A3 (en)
DE (1) DE59410179D1 (en)
HU (1) HUT68042A (en)
WO (1) WO1994018185A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5776718A (en) * 1995-03-24 1998-07-07 Arris Pharmaceutical Corporation Reversible protease inhibitors
KR0173034B1 (en) * 1995-04-28 1999-03-30 성재갑 Selective thrombin inhibitor
TW438591B (en) * 1995-06-07 2001-06-07 Arris Pharm Corp Reversible cysteine protease inhibitors
EP0880501A1 (en) 1996-02-02 1998-12-02 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
GB9602294D0 (en) * 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
SK18499A3 (en) * 1996-08-14 1999-07-12 Zeneca Ltd Substituted pyrimidine derivatives and their pharmaceutical use
GB9621814D0 (en) * 1996-10-19 1996-12-11 British Biotech Pharm Metalloproteinase inhibitors
UA56197C2 (en) 1996-11-08 2003-05-15 Зенека Лімітед Heterocyclic derivatives
JP2001511799A (en) 1997-02-13 2001-08-14 ゼネカ・リミテッド Heterocyclic compounds useful as oxide-squalene cyclase inhibitors
EP0966460A1 (en) 1997-02-13 1999-12-29 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
KR100373373B1 (en) * 1997-04-03 2003-05-16 주식회사 엘지생명과학 Selective thrombin inhibitor
KR19980075899A (en) * 1997-04-03 1998-11-16 성재갑 Selective thrombin inhibitor
KR19980077254A (en) * 1997-04-17 1998-11-16 성재갑 Selective thrombin inhibitor
AU7453498A (en) 1997-05-30 1998-12-30 Takeda Chemical Industries Ltd. Sulfonamide derivatives, their production and use
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
CA2317017A1 (en) 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
JP4603162B2 (en) 1998-07-20 2010-12-22 ヴィレックス アクチェンゲゼルシャフト New urokinase inhibitor
US7342018B2 (en) 1998-07-20 2008-03-11 Wilex Ag Urokinase inhibitors and uses thereof
EP1114024B1 (en) * 1998-09-18 2002-11-27 Pentapharm A.G. Urokinase inhibitors
CZ20012379A3 (en) 1999-01-02 2001-09-12 Aventis Pharma Deutschland Gmbh Novel derivatives of malonic acid; process of their preparation, use and pharmaceutical preparations in which these derivatives (factor Xa activity inhibitors) are comprised
EP1016663A1 (en) * 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
EP1127884A1 (en) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
JP2004520438A (en) 2001-03-09 2004-07-08 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Aminopyrrolidine sulfonamides as serine protease inhibitors
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
CA2478409C (en) 2002-03-11 2012-07-31 Curacyte Ag Inhibitors of urokinase, their preparation and use
CN1747732A (en) * 2002-12-11 2006-03-15 舍林股份公司 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
DE10301300B4 (en) 2003-01-15 2009-07-16 Curacyte Chemistry Gmbh Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
DE10322191B4 (en) 2003-05-16 2014-02-27 The Medicines Company (Leipzig) Gmbh N-sulfonylated amino acid derivatives, process for their preparation and their use
DE10342108A1 (en) 2003-09-11 2005-04-14 Curacyte Chemistry Gmbh Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use
DE102006050672A1 (en) 2006-10-24 2008-04-30 Curacyte Discovery Gmbh New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
US11130780B2 (en) 2015-03-09 2021-09-28 Washington University Inhibitors of growth factor activation enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD142804A3 (en) * 1977-11-07 1980-07-16 Wagner Guenter PROCESS FOR PREPARING NA-ALKYL-BZW.NA-ARYL-SULFONYLATED OMEGA-AMIDINOPHENYL-ALPHA-AMINOALKYLCARBONESAFEAMIDES
SE8203887D0 (en) * 1982-06-23 1982-06-23 Kabivitrum Ab NEW TROMBIN INHIBITIVE ASSOCIATIONS
CA2073776A1 (en) * 1990-11-15 1992-05-16 Joerg Stuerzebecher Meta-substituted phenyl alanine derivatives

Also Published As

Publication number Publication date
EP0635008A1 (en) 1995-01-25
AU5878194A (en) 1994-08-29
KR950703543A (en) 1995-09-20
CA2133761A1 (en) 1994-08-18
EP0635008B1 (en) 2002-09-04
CZ245994A3 (en) 1995-10-18
JPH07509731A (en) 1995-10-26
DE59410179D1 (en) 2002-10-10
HU9402923D0 (en) 1995-01-30
ATE223392T1 (en) 2002-09-15
WO1994018185A1 (en) 1994-08-18
US5607937A (en) 1997-03-04

Similar Documents

Publication Publication Date Title
HUT68042A (en) Piperazides of substituted phenylalanine derivates as thrombin inhibitors
IL126610A0 (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
CA2226256A1 (en) New thrombin inhibitors, their preparation and use
MY132115A (en) Novel thrombin inhibitors
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
CA2200192A1 (en) Amidino and Guanidino Substituted Inhibitors of Trypsin-Like Enzymes
CA2294059A1 (en) New amidino derivatives and their use as thrombin inhibitors
GEP20012390B (en) Benzonaphthyridines as Bronchial Therapeutics
PL327986A1 (en) Amidinic inhibitors of proteases
IL108797A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
MY115211A (en) Novel amino acid derivatives, their preparation and use
NZ331484A (en) Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases
AP9600810A0 (en) Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation.
PL348972A1 (en) New amidino derivatives and their use as thrombin inhibitors
CZ92298A3 (en) Guanidine protease inhibitors
MX9801190A (en) Prolylendopeptidase inhibitors.
MY118244A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
AU3183801A (en) Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
EP1008348A4 (en) Thrombolytic agent
EP1118615A4 (en) Novel salts of pyridopyrazine compound and crystals thereof
GB2333294A (en) Cytokine production inhibitors
AU3617489A (en) A peptide with antihypertensive activity
DK0832085T3 (en) Phosphinic acid derivatives with metallopeptidase inhibitory activity
CA2183320A1 (en) Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
ES2104416T3 (en) GLYCOSILAMIDES OF 2-AMINOACILAMINO-2-DESOXI-SUGARS.

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal
DFC4 Cancellation of temporary protection due to refusal